---
document_datetime: 2023-09-21 19:34:03
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cyltezo-epar-all-authorised-presentations_en.pdf
document_name: cyltezo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.2800555
conversion_datetime: 2025-12-25 02:41:48.138724
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging                                 | Content (concentration)   | Pack size                                                             |
|------------------|-------------------|------------|------------------------|---------------------------|-----------------------------------------------------|---------------------------|-----------------------------------------------------------------------|
| EU/1/17/1240/001 | Cyltezo           | 40 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass)                          | 0.8 ml (40 mg/0.8 ml)     | 1 pre-filled syringe in a blister + 2                                 |
| EU/1/17/1240/002 | Cyltezo           | 40 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass)                          | 0.8 ml (40 mg/0.8 ml)     | alcohol pads 2 pre-filled syringes, each in a blister,+2 alcohol pads |
| EU/1/17/1240/003 | Cyltezo           | 40 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass)                          | 0.8 ml (40 mg/0.8 ml)     | 4 pre-filled syringes, each in a blister,+4                           |
| EU/1/17/1240/004 | Cyltezo           | 40 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass)                          | 0.8 ml (40 mg/0.8 ml)     | alcohol pads 6 pre-filled syringes, each in a blister,+6 alcohol pads |
| EU/1/17/1240/005 | Cyltezo           | 40 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) in pre-filled pen longer | 0.8 ml (40 mg/0.8 ml)     | 1 pre-filled pen in a blister + 2 alcohol pads                        |
| EU/1/17/1240/006 | Cyltezo           | 40 mg      | Solution for injection | Subcutaneous use no       | pre-filled syringe (glass) in pre-filled pen        | 0.8 ml (40 mg/0.8 ml)     | 2 pre-filled pens, each in a blister,+2 alcohol pads                  |
| EU/1/17/1240/007 | Cyltezo           | 40 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) in pre-filled pen        | 0.8 ml (40 mg/0.8 ml)     | 4 pre-filled pens, each in a blister,+4                               |
| EU/1/17/1240/008 | Cyltezo           | 40 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) in pre-filled pen        | 0.8 ml (40 mg/0.8 ml)     | alcohol pads 6 pre-filled pens, each in a blister,+6 alcohol pads     |

1/1 edicinal product no longer authorised